1. Home
  2. TRVI vs VSTS Comparison

TRVI vs VSTS Comparison

Compare TRVI & VSTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRVI
  • VSTS
  • Stock Information
  • Founded
  • TRVI 2011
  • VSTS 1936
  • Country
  • TRVI United States
  • VSTS United States
  • Employees
  • TRVI N/A
  • VSTS N/A
  • Industry
  • TRVI Biotechnology: Pharmaceutical Preparations
  • VSTS
  • Sector
  • TRVI Health Care
  • VSTS
  • Exchange
  • TRVI Nasdaq
  • VSTS Nasdaq
  • Market Cap
  • TRVI 725.7M
  • VSTS 819.7M
  • IPO Year
  • TRVI 2019
  • VSTS N/A
  • Fundamental
  • Price
  • TRVI $8.07
  • VSTS $4.22
  • Analyst Decision
  • TRVI Strong Buy
  • VSTS Sell
  • Analyst Count
  • TRVI 9
  • VSTS 4
  • Target Price
  • TRVI $20.72
  • VSTS $9.13
  • AVG Volume (30 Days)
  • TRVI 2.9M
  • VSTS 1.7M
  • Earning Date
  • TRVI 11-05-2025
  • VSTS 08-05-2025
  • Dividend Yield
  • TRVI N/A
  • VSTS 1.66%
  • EPS Growth
  • TRVI N/A
  • VSTS N/A
  • EPS
  • TRVI N/A
  • VSTS N/A
  • Revenue
  • TRVI N/A
  • VSTS $2,707,109,000.00
  • Revenue This Year
  • TRVI N/A
  • VSTS N/A
  • Revenue Next Year
  • TRVI N/A
  • VSTS $0.25
  • P/E Ratio
  • TRVI N/A
  • VSTS N/A
  • Revenue Growth
  • TRVI N/A
  • VSTS N/A
  • 52 Week Low
  • TRVI $2.36
  • VSTS $3.98
  • 52 Week High
  • TRVI $9.92
  • VSTS $17.83
  • Technical
  • Relative Strength Index (RSI)
  • TRVI 53.13
  • VSTS 37.66
  • Support Level
  • TRVI $6.93
  • VSTS $3.98
  • Resistance Level
  • TRVI $9.92
  • VSTS $4.37
  • Average True Range (ATR)
  • TRVI 0.76
  • VSTS 0.21
  • MACD
  • TRVI 0.11
  • VSTS 0.02
  • Stochastic Oscillator
  • TRVI 37.96
  • VSTS 29.01

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

About VSTS Vestis Corporation

Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.

Share on Social Networks: